HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Bin Li Selected Research

methyl ester 5(S),6(R)-7-trihydroxyheptanoic acid

4/2019BML-111 accelerates the resolution of inflammation by modulating the Nrf2/HO-1 and NF-κB pathways in rats with ventilator-induced lung injury.
8/2013BML-111 attenuates hemorrhagic shock-induced acute lung injury through inhibiting activation of mitogen-activated protein kinase pathway in rats.
7/2012BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats.
7/2012Lipoxin receptor agonist, may be a potential treatment for hemorrhagic shock-induced acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Bin Li Research Topics

Disease

4Acute Lung Injury
10/2015 - 07/2012
3Autism Spectrum Disorder
01/2020 - 01/2019
2Neoplasms (Cancer)
01/2022 - 06/2010
2Inflammation (Inflammations)
04/2019 - 10/2015
2Hemorrhagic Shock
08/2013 - 07/2012
1Thrombosis (Thrombus)
06/2022
1Respiratory Insufficiency (Respiratory Failure)
06/2022
1Hemorrhage
06/2022
1Nervous System Diseases (Neurological Disorders)
01/2022
1Infections
01/2022
1Mycoses (Diseases, Fungus)
01/2022
1Pulmonary Edema
04/2019
1Lung Injury
04/2019
1Ventilator-Induced Lung Injury
04/2019
1Hepatic Encephalopathy
01/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2016
1Hypospadias
05/2016
1Purpura
04/2015
1Erectile Dysfunction
07/2014
1Reperfusion Injury
08/2013
1Cicatrix (Scar)
05/2013
1Candidiasis (Moniliasis)
01/2013
1Shock
07/2012
1Peritonitis
07/2012
1Brain Ischemia (Cerebral Ischemia)
07/2012
1Spinal Stenosis (Stenosis, Spinal)
06/2008
1Burns
04/2003
1Sepsis (Septicemia)
04/2003

Drug/Important Bio-Agent (IBA)

4methyl ester 5(S),6(R)-7-trihydroxyheptanoic acidIBA
04/2019 - 07/2012
3LipoxinsIBA
08/2013 - 07/2012
2salicylhydroxamic acid (SHAM)IBA
08/2013 - 07/2012
2CytokinesIBA
07/2012 - 04/2003
1Heparin (Liquaemin)FDA LinkGeneric
06/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1S-Adenosylmethionine (Ademetionine)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1HomocysteineIBA
01/2020
1Methionine (L-Methionine)FDA Link
01/2020
1S-AdenosylhomocysteineIBA
01/2020
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2019
1AmmoniaIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
07/2016
1Tumor Necrosis Factor alpha-Induced Protein 3IBA
07/2016
17,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA
10/2015
1CaspasesIBA
10/2015
1LipopolysaccharidesIBA
10/2015
1Docosahexaenoic AcidsIBA
10/2015
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
10/2015
1Immunoglobulin A (IgA)IBA
04/2015
1Immunoglobulin G (IgG)IBA
04/2015
1Mitogen-Activated Protein KinasesIBA
08/2013
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2013
1lipoxin A4IBA
08/2013
1Collagen Type I (Type I Collagen)IBA
05/2013
1Small Interfering RNA (siRNA)IBA
05/2013
1Amphotericin B (Amphotericin)FDA LinkGeneric
01/2013
1Peroxidase (Myeloperoxidase)IBA
07/2012
1Therapeutic UsesIBA
06/2008
1EndotoxinsIBA
04/2003

Therapy/Procedure

2Resuscitation
08/2013 - 07/2012
1Oxygenators
06/2022
1Extracorporeal Membrane Oxygenation
06/2022
1Length of Stay
01/2022
1Indwelling Catheters (Indwelling Catheter)
01/2022
1Transjugular Intrahepatic Portasystemic Shunt
01/2018
1Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2018
1Inlays (Inlay)
05/2016
1Electrocoagulation (Electrocautery)
07/2014
1Therapeutics
07/2014
1Prostatectomy (Retropubic Prostatectomy)
07/2014
1Cystectomy
06/2010
1Laminoplasty
06/2008
1Continuous Renal Replacement Therapy
04/2003